Cite
Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study
MLA
Zhi-Ran Yang, et al. “Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study.” Frontiers in Oncology, vol. 12, July 2022. EBSCOhost, https://doi.org/10.3389/fonc.2022.811800.
APA
Zhi-Ran Yang, Yan-Dong Su, Ru Ma, He-Liang Wu, & Yan Li. (2022). Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.811800
Chicago
Zhi-Ran Yang, Yan-Dong Su, Ru Ma, He-Liang Wu, and Yan Li. 2022. “Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study.” Frontiers in Oncology 12 (July). doi:10.3389/fonc.2022.811800.